Cerence (CRNC) Financials

$7.59 +0.25 (+3.41%)

Closing price 04/17/2025 04:00 PM Eastern

Extended Trading

$7.50 -0.09 (-1.25%)

As of 04/17/2025 06:21 PM Eastern

Annual Income Statements for Cerence

This table shows Cerence's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-311	-56	-588
Consolidated Net Income / (Loss)	-311	-56	-588
Net Income / (Loss) Continuing Operations	-311	-56	-588
Total Pre-Tax Income	-199	-36	-585
Total Operating Income	-184	-27	-580
Total Gross Profit	231	199	244
Total Revenue	328	294	332
Operating Revenue	328	294	332
Total Cost of Revenue	97	95	87
Operating Cost of Revenue	97	95	87
Total Operating Expenses	415	227	824
Selling, General & Admin Expense	43	58	52
Marketing Expense	31	28	22
Research & Development Expense	107	123	122
Amortization Expense	12	5.85	2.20
Impairment Charge	214	0.00	609
Restructuring Charge	8.97	12	17
Total Other Income / (Expense), net	-14	-9.19	-4.67
Interest Expense	14	15	13
Interest & Investment Income	1.01	4.47	5.35
Other Income / (Expense), net	-1.02	1.11	2.53
Income Tax Expense	112	20	3.47
Basic Earnings per Share	($7.93)	($1.40)	($14.12)
Weighted Average Basic Shares Outstanding	39.19M	40.22M	41.64M
Diluted Earnings per Share	($7.93)	($1.40)	($14.12)
Weighted Average Diluted Shares Outstanding	39.19M	40.22M	41.64M
Weighted Average Basic & Diluted Shares Outstanding	39.94M	41.14M	42.83M

This table shows Cerence's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Income / (Loss) Attributable to Common Shareholders	-99	-230	-2.16	-26	-16	-12	24	-278	-314	-20	-24
Consolidated Net Income / (Loss)	-99	-230	-2.16	-26	-16	-12	24	-278	-314	-20	-24
Net Income / (Loss) Continuing Operations	-99	-230	-2.16	-26	-16	-12	24	-278	-314	-20	-24
Total Pre-Tax Income	12	-233	-0.91	-22	-13	0.35	58	-266	-356	-20	-19
Total Operating Income	16	-229	-1.98	-21	-8.50	3.90	59	-264	-355	-19	-17
Total Gross Profit	65	34	57	43	41	58	112	47	50	35	33
Total Revenue	89	58	84	68	62	81	138	68	71	55	51
Operating Revenue	89	58	84	68	62	81	138	68	71	55	51
Total Cost of Revenue	24	24	26	25	21	23	26	21	20	20	18
Operating Cost of Revenue	24	24	26	25	21	23	26	21	20	20	18
Total Operating Expenses	49	263	59	64	49	54	53	311	405	54	50
Selling, General & Admin Expense	11	11	14	19	13	11	13	17	9.83	13	13
Marketing Expense	8.30	8.61	9.16	8.22	4.28	5.85	6.07	5.62	5.21	4.83	4.77
Research & Development Expense	26	25	29	28	30	35	33	32	31	25	21
Amortization Expense	2.86	-	2.35	2.39	0.55	0.56	0.55	0.56	0.55	0.55	0.55
Restructuring Charge	1.20	2.38	4.19	5.71	1.17	0.84	0.71	4.55	1.49	10	11
Total Other Income / (Expense), net	-4.05	-3.46	1.07	-1.77	-4.94	-3.55	-0.38	-1.95	-1.19	-1.16	-1.68
Interest Expense	3.82	3.79	3.51	4.00	4.12	3.13	3.24	3.11	3.10	3.10	3.39
Interest & Investment Income	0.24	0.59	0.87	1.16	1.21	1.23	1.43	1.19	1.29	1.44	1.44
Other Income / (Expense), net	-0.48	-0.26	3.71	1.07	-2.03	-1.65	1.42	-0.03	0.63	0.50	0.27
Income Tax Expense	111	-2.66	1.25	3.71	3.01	12	34	12	-43	0.03	5.67
Basic Earnings per Share	($2.53)	($5.88)	($0.05)	($0.65)	($0.41)	($0.29)	$0.58	($6.66)	($7.50)	($0.54)	($0.57)
Weighted Average Basic Shares Outstanding	39.31M	39.19M	39.96M	40.22M	40.32M	40.22M	41.19M	41.72M	41.80M	41.64M	42.90M
Diluted Earnings per Share	($2.53)	($5.86)	($0.05)	($0.65)	($0.41)	($0.29)	$0.53	($6.66)	($7.50)	($0.49)	($0.57)
Weighted Average Diluted Shares Outstanding	39.31M	39.19M	39.96M	40.22M	40.32M	40.22M	49.26M	41.72M	41.80M	41.64M	42.90M
Weighted Average Basic & Diluted Shares Outstanding	39.38M	39.94M	40.23M	40.31M	40.33M	41.14M	41.67M	41.78M	41.80M	42.83M	43.20M

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	-34	6.31	20
Net Cash From Operating Activities	-2.14	7.50	17
Net Cash From Continuing Operating Activities	-2.14	7.50	17
Net Income / (Loss) Continuing Operations	-311	-56	-588
Consolidated Net Income / (Loss)	-311	-56	-588
Depreciation Expense	24	16	11
Non-Cash Adjustments To Reconcile Net Income	252	45	641
Changes in Operating Assets and Liabilities, net	32	2.47	-46
Net Cash From Investing Activities	-11	5.82	4.38
Net Cash From Continuing Investing Activities	-11	5.82	4.38
Purchase of Property, Plant & Equipment	-17	-5.12	-5.00
Purchase of Investments	-32	-18	0.00
Sale and/or Maturity of Investments	37	30	11
Other Investing Activities, net	2.02	-1.36	-1.74
Net Cash From Financing Activities	-20	-5.33	0.23
Net Cash From Continuing Financing Activities	-20	-5.33	0.23
Repayment of Debt	-6.25	-240	-0.42
Repurchase of Common Equity	-49	-4.89	-9.87
Issuance of Debt	0.00	235	0.00
Issuance of Common Equity	36	5.63	11
Other Financing Activities, net	-0.42	-0.45	-0.39
Effect of Exchange Rate Changes	-1.27	-1.68	-1.47
Cash Interest Paid	9.09	12	6.03
Cash Income Taxes Paid	12	11	10

This table details how cash moves in and out of Cerence's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Change in Cash & Equivalents	-3.37	-14	-4.19	4.72	-9.28	15	-2.42	0.44	16	5.96	-17
Net Cash From Operating Activities	-3.93	-4.95	-2.12	6.56	-8.20	11	-2.82	1.04	13	6.12	9.25
Net Cash From Continuing Operating Activities	-3.93	-4.95	-2.12	6.56	-8.20	11	-2.82	1.04	13	6.12	9.25
Net Income / (Loss) Continuing Operations	-99	-230	-2.16	-26	-16	-12	24	-278	-314	-20	-24
Consolidated Net Income / (Loss)	-99	-230	-2.16	-26	-16	-12	24	-278	-314	-20	-24
Depreciation Expense	5.28	5.09	5.01	5.03	3.12	2.89	2.69	2.70	2.67	2.58	2.45
Non-Cash Adjustments To Reconcile Net Income	10	221	6.83	16	9.87	12	7.84	266	363	3.92	12
Changes in Operating Assets and Liabilities, net	80	-0.92	-12	12	-4.73	7.45	-37	10	-39	20	20
Net Cash From Investing Activities	2.55	-7.15	1.52	0.71	-4.67	8.27	1.19	-0.94	4.08	0.05	0.76
Net Cash From Continuing Investing Activities	2.55	-7.15	1.52	0.71	-4.67	8.27	1.19	-0.94	4.08	0.05	0.76
Purchase of Property, Plant & Equipment	-4.43	-3.03	-0.68	-1.39	-1.52	-1.53	-0.93	-1.85	-0.77	-1.45	-1.36
Sale and/or Maturity of Investments	15	6.20	9.50	6.40	4.30	10	2.44	1.47	5.30	1.91	2.49
Other Investing Activities, net	0.47	0.28	-0.22	-0.33	-0.47	-0.33	-0.32	-0.57	-0.44	-0.41	-0.37
Net Cash From Financing Activities	-1.66	-1.61	-3.05	-2.39	4.42	-4.31	-0.13	0.65	-0.46	0.17	-27
Net Cash From Continuing Financing Activities	-1.66	-1.61	-3.05	-2.39	4.42	-4.31	-0.13	0.65	-0.46	0.17	-27
Repayment of Debt	-1.56	-1.56	-1.97	-3.13	-210	-25	0.00	-	-0.42	-	-27
Repurchase of Common Equity	-1.54	-1.04	-2.64	-1.79	-0.40	-0.06	-6.21	-3.54	-0.11	-0.01	-1.37
Issuance of Common Equity	1.48	1.12	1.72	2.67	0.29	0.94	6.20	4.26	0.18	0.26	1.36
Other Financing Activities, net	-0.04	-0.13	-0.17	-0.15	-0.04	-0.10	-0.12	-0.08	-0.10	-0.09	-0.12
Effect of Exchange Rate Changes	-0.33	0.11	-0.54	-0.15	-0.83	-0.16	-0.66	-0.31	-0.13	-0.37	-0.31
Cash Interest Paid	3.57	1.36	4.34	2.15	4.98	0.10	3.00	0.07	1.31	1.64	3.08
Cash Income Taxes Paid	3.27	2.41	2.46	1.59	1.70	5.43	3.10	3.15	1.79	2.13	0.01

This table presents Cerence's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Total Assets	1,318	1,298	702
Total Current Assets	228	226	266
Cash & Equivalents	95	101	121
Short-Term Investments	20	9.21	5.50
Accounts Receivable	45	61	63
Prepaid Expenses	60	47	70
Other Current Assets	7.10	6.94	5.29
Plant, Property, & Equipment, net	38	34	30
Total Noncurrent Assets	1,053	1,038	407
Long-Term Investments	12	11	3.45
Goodwill	891	900	297
Intangible Assets	9.70	3.88	1.71
Noncurrent Deferred & Refundable Income Taxes	52	47	51
Other Noncurrent Operating Assets	89	76	53
Total Liabilities & Shareholders' Equity	1,318	1,298	702
Total Liabilities	606	603	561
Total Current Liabilities	147	148	217
Short-Term Debt	11	0.00	87
Accounts Payable	10	17	3.96
Accrued Expenses	48	49	68
Current Deferred Revenue	73	77	53
Other Current Liabilities	5.07	5.43	4.53
Total Noncurrent Liabilities	459	455	344
Long-Term Debt	259	276	195
Noncurrent Deferred Revenue	166	146	114
Other Noncurrent Operating Liabilities	33	33	35
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	713	695	141
Total Preferred & Common Equity	713	695	141
Total Common Equity	713	695	141
Common Stock	1,030	1,057	1,089
Retained Earnings	-283	-334	-922
Accumulated Other Comprehensive Income / (Loss)	-34	-28	-26

This table presents Cerence's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Total Assets	1,577	1,348	1,335	1,312	1,265	987	674	618
Total Current Assets	255	242	232	219	228	233	240	200
Cash & Equivalents	108	91	95	86	99	99	116	104
Short-Term Investments	19	17	12	17	9.78	9.36	5.44	3.89
Accounts Receivable	63	66	61	57	59	67	73	48
Prepaid Expenses	58	61	56	52	56	52	40	40
Other Current Assets	7.42	7.78	7.71	7.59	5.57	5.30	5.56	4.74
Plant, Property, & Equipment, net	38	37	36	35	33	32	31	29
Total Noncurrent Assets	1,284	1,069	1,068	1,058	1,004	722	404	388
Long-Term Investments	8.78	13	16	13	7.76	6.71	5.34	2.55
Goodwill	1,115	902	904	905	906	651	292	289
Intangible Assets	13	7.71	5.30	4.64	3.37	2.75	2.18	1.06
Noncurrent Deferred & Refundable Income Taxes	50	54	54	52	17	7.06	50	46
Other Noncurrent Operating Assets	98	92	89	83	70	55	54	50
Total Liabilities & Shareholders' Equity	1,577	1,348	1,335	1,312	1,265	987	674	618
Total Liabilities	627	628	626	609	534	524	520	497
Total Current Liabilities	154	165	166	168	120	107	183	152
Short-Term Debt	9.38	13	13	25	0.00	0.00	87	60
Accounts Payable	15	19	19	16	19	16	10	7.61
Accrued Expenses	49	52	53	47	52	40	38	33
Current Deferred Revenue	75	76	76	75	43	45	44	48
Other Current Liabilities	5.49	5.76	6.00	5.51	5.68	5.19	4.65	3.83
Total Noncurrent Liabilities	472	463	460	441	414	417	337	345
Long-Term Debt	261	267	265	255	277	279	193	196
Noncurrent Deferred Revenue	174	162	160	153	101	103	109	113
Other Noncurrent Operating Liabilities	38	33	35	33	35	35	34	35
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	950	720	709	703	731	463	154	121
Total Preferred & Common Equity	950	720	709	703	731	463	154	121
Total Common Equity	950	720	709	703	731	463	154	121
Common Stock	1,024	1,024	1,038	1,050	1,064	1,078	1,084	1,097
Retained Earnings	-53	-280	-306	-322	-310	-588	-901	-946
Accumulated Other Comprehensive Income / (Loss)	-21	-24	-23	-25	-23	-27	-29	-30

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	-15.31%	-10.19%	12.57%
EBITDA Growth	-275.81%	93.77%	-5,537.92%
EBIT Growth	-398.22%	85.92%	-2,113.06%
NOPAT Growth	-323.99%	85.25%	-2,032.20%
Net Income Growth	-777.28%	81.90%	-945.40%
EPS Growth	-777.78%	82.35%	-908.57%
Operating Cash Flow Growth	-102.87%	450.70%	129.34%
Free Cash Flow Firm Growth	2,428.98%	-108.13%	1,328.64%
Invested Capital Growth	-24.67%	-0.78%	-65.57%
Revenue Q/Q Growth	-10.86%	8.32%	-7.26%
EBITDA Q/Q Growth	-298.43%	95.81%	-3.90%
EBIT Q/Q Growth	-436.33%	89.88%	-3.77%
NOPAT Q/Q Growth	-32.25%	89.56%	-4.15%
Net Income Q/Q Growth	-327.50%	79.53%	-1.53%
EPS Q/Q Growth	-326.34%	79.91%	-1.44%
Operating Cash Flow Q/Q Growth	-108.18%	186.06%	-23.02%
Free Cash Flow Firm Q/Q Growth	429.64%	-134.16%	-10.01%
Invested Capital Q/Q Growth	-21.02%	-1.89%	-5.10%
Profitability Metrics	-	-	-
Gross Margin	70.37%	67.68%	73.69%
EBITDA Margin	-49.23%	-3.41%	-170.97%
Operating Margin	-56.22%	-9.24%	-174.94%
EBIT Margin	-56.53%	-8.86%	-174.18%
Profit (Net Income) Margin	-94.80%	-19.10%	-177.40%
Tax Burden Percent	156.39%	154.59%	100.59%
Interest Burden Percent	107.22%	139.47%	101.25%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-12.95%	-2.23%	-71.07%
ROIC Less NNEP Spread (ROIC-NNEP)	-159.09%	-27.16%	-189.93%
Return on Net Nonoperating Assets (RNNOA)	-22.68%	-5.76%	-69.62%
Return on Equity (ROE)	-35.63%	-7.99%	-140.69%
Cash Return on Invested Capital (CROIC)	15.20%	-1.44%	26.49%
Operating Return on Assets (OROA)	-12.26%	-1.99%	-57.74%
Return on Assets (ROA)	-20.56%	-4.30%	-58.81%
Return on Common Equity (ROCE)	-35.63%	-7.99%	-140.69%
Return on Equity Simple (ROE_SIMPLE)	-43.60%	-8.10%	-416.79%
Net Operating Profit after Tax (NOPAT)	-129	-19	-406
NOPAT Margin	-39.36%	-6.47%	-122.46%
Net Nonoperating Expense Percent (NNEP)	146.15%	24.93%	118.86%
Cost of Revenue to Revenue	29.63%	32.32%	26.31%
SG&A Expenses to Revenue	13.01%	19.66%	15.83%
R&D to Revenue	32.67%	41.88%	36.67%
Operating Expenses to Revenue	126.59%	76.92%	248.63%
Earnings before Interest and Taxes (EBIT)	-185	-26	-577
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-161	-10	-567
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.87	1.18	0.93
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.89	2.79	0.40
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.89	1.15	0.97
Enterprise Value to Revenue (EV/Rev)	2.33	3.32	0.85
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	130.24	16.47
Enterprise Value to Free Cash Flow (EV/FCFF)	5.04	0.00	1.87
Leverage & Solvency	-	-	-
Debt to Equity	0.38	0.40	2.00
Long-Term Debt to Equity	0.36	0.40	1.38
Financial Leverage	0.14	0.21	0.37
Leverage Ratio	1.73	1.86	2.39
Compound Leverage Factor	1.86	2.59	2.42
Debt to Total Capital	27.50%	28.42%	66.64%
Short-Term Debt to Total Capital	1.11%	0.00%	20.59%
Long-Term Debt to Total Capital	26.38%	28.42%	46.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	72.50%	71.58%	33.36%
Debt to EBITDA	-1.67	-27.45	-0.50
Net Debt to EBITDA	-0.89	-15.42	-0.27
Long-Term Debt to EBITDA	-1.61	-27.45	-0.34
Debt to NOPAT	-2.10	-14.49	-0.69
Net Debt to NOPAT	-1.11	-8.14	-0.37
Long-Term Debt to NOPAT	-2.01	-14.49	-0.48
Altman Z-Score	0.17	0.69	-3.85
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.55	1.52	1.22
Quick Ratio	1.09	1.16	0.88
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	151	-12	151
Operating Cash Flow to CapEx	-12.26%	146.33%	344.20%
Free Cash Flow to Firm to Interest Expense	10.52	-0.83	12.06
Operating Cash Flow to Interest Expense	-0.15	0.51	1.37
Operating Cash Flow Less CapEx to Interest Expense	-1.36	0.16	0.97
Efficiency Ratios	-	-	-
Asset Turnover	0.22	0.23	0.33
Accounts Receivable Turnover	7.24	5.54	5.35
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	9.48	8.21	10.34
Accounts Payable Turnover	8.83	6.99	8.37
Days Sales Outstanding (DSO)	50.45	65.91	68.28
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	41.34	52.25	43.58
Cash Conversion Cycle (CCC)	9.11	13.66	24.70
Capital & Investment Metrics	-	-	-
Invested Capital	857	850	293
Invested Capital Turnover	0.33	0.35	0.58
Increase / (Decrease) in Invested Capital	-281	-6.72	-557
Enterprise Value (EV)	764	977	283
Market Capitalization	620	822	132
Book Value per Share	$18.10	$17.23	$3.38
Tangible Book Value per Share	($4.76)	($5.19)	($3.77)
Total Capital	983	971	423
Total Debt	270	276	282
Total Long-Term Debt	259	276	195
Net Debt	144	155	151
Capital Expenditures (CapEx)	17	5.12	5.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-24	-33	8.81
Debt-free Net Working Capital (DFNWC)	91	78	136
Net Working Capital (NWC)	80	78	49
Net Nonoperating Expense (NNE)	182	37	182
Net Nonoperating Obligations (NNO)	144	155	151
Total Depreciation and Amortization (D&A)	24	16	11
Debt-free, Cash-free Net Working Capital to Revenue	-7.24%	-11.12%	2.66%
Debt-free Net Working Capital to Revenue	27.88%	26.36%	40.96%
Net Working Capital to Revenue	24.55%	26.36%	14.69%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($7.93)	($1.40)	($14.12)
Adjusted Weighted Average Basic Shares Outstanding	39.19M	40.22M	41.64M
Adjusted Diluted Earnings per Share	($7.93)	($1.40)	($14.12)
Adjusted Weighted Average Diluted Shares Outstanding	39.19M	40.22M	41.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.94M	41.14M	42.83M
Normalized Net Operating Profit after Tax (NOPAT)	27	-11	32
Normalized NOPAT Margin	8.19%	-3.63%	9.78%
Pre Tax Income Margin	-60.62%	-12.36%	-176.35%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-12.88	-1.77	-46.00
NOPAT to Interest Expense	-8.97	-1.29	-32.34
EBIT Less CapEx to Interest Expense	-14.09	-2.11	-46.40
NOPAT Less CapEx to Interest Expense	-10.18	-1.64	-32.74
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-15.77%	-8.70%	-1.68%

This table displays calculated financial ratios and metrics derived from Cerence's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-8.02%	-40.72%	-11.40%	-20.73%	-30.75%	38.90%	65.36%	-0.83%	14.40%	-32.14%	-63.21%
EBITDA Growth	-8.34%	-1,328.54%	-77.44%	-215.13%	-136.02%	102.29%	829.54%	-1,702.66%	-4,643.21%	-414.45%	-122.68%
EBIT Growth	1.17%	-2,208.45%	-92.35%	-412.89%	-168.83%	100.98%	3,356.34%	-1,252.96%	-3,264.15%	-933.33%	-127.77%
NOPAT Growth	-1,927.72%	-1,500.91%	-106.13%	-1,333.40%	95.54%	18.97%	1,835.21%	-1,182.35%	-4,074.86%	89.65%	-149.36%
Net Income Growth	-1,812.09%	-2,979.83%	-111.33%	-5,380.88%	83.42%	94.98%	1,205.51%	-965.49%	-1,805.46%	-76.73%	-201.81%
EPS Growth	-1,786.67%	-2,890.48%	-110.64%	-6,400.00%	83.79%	95.05%	1,160.00%	-924.62%	-1,729.27%	-68.97%	-207.55%
Operating Cash Flow Growth	-116.33%	-121.24%	-141.17%	310.20%	-108.68%	327.30%	-32.91%	-84.07%	256.79%	-45.68%	428.74%
Free Cash Flow Firm Growth	-65.16%	398.72%	4,087.48%	800.59%	359.26%	-202.82%	-96.10%	-82.89%	45.71%	540.87%	5,385.23%
Invested Capital Growth	-4.54%	-24.67%	-24.69%	-26.85%	-20.13%	-0.78%	1.46%	-27.42%	-64.41%	-65.57%	-70.15%
Revenue Q/Q Growth	3.20%	-34.70%	43.88%	-18.25%	-9.84%	30.98%	71.28%	-50.97%	4.00%	-22.31%	-7.13%
EBITDA Q/Q Growth	63.19%	-1,190.99%	103.00%	-315.27%	48.94%	169.26%	1,121.04%	-517.48%	-34.35%	95.41%	11.94%
EBIT Q/Q Growth	144.94%	-1,600.68%	100.76%	-1,225.75%	46.11%	121.34%	2,570.32%	-540.67%	-33.99%	94.71%	11.02%
NOPAT Q/Q Growth	-13,164.35%	-20.21%	99.14%	-942.84%	58.77%	-2,085.91%	118.46%	-870.68%	-34.24%	94.58%	11.94%
Net Income Q/Q Growth	-20,754.41%	-131.83%	99.06%	-1,108.94%	36.93%	29.80%	306.52%	-1,265.18%	-12.80%	93.49%	-18.97%
EPS Q/Q Growth	-25,200.00%	-131.62%	99.15%	-1,200.00%	36.92%	29.27%	282.76%	-1,356.60%	-12.61%	93.47%	-16.33%
Operating Cash Flow Q/Q Growth	-345.81%	-26.09%	57.24%	409.49%	-225.05%	237.34%	-125.00%	137.09%	1,131.03%	-52.42%	51.33%
Free Cash Flow Firm Q/Q Growth	-89.69%	246.44%	139.11%	5.48%	-29.80%	-158.08%	109.08%	362.51%	497.71%	75.71%	12.92%
Invested Capital Q/Q Growth	-8.16%	-21.02%	2.67%	-1.77%	0.27%	-1.89%	4.99%	-29.73%	-50.84%	-5.10%	-8.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	72.76%	58.06%	68.70%	63.43%	66.04%	71.49%	80.96%	69.21%	71.50%	63.67%	64.98%
EBITDA Margin	23.11%	-386.12%	8.06%	-21.23%	-12.02%	6.36%	45.32%	-385.86%	-498.47%	-29.46%	-27.93%
Operating Margin	17.72%	-394.42%	-2.36%	-30.14%	-13.79%	4.82%	42.35%	-389.80%	-503.13%	-35.08%	-33.27%
EBIT Margin	17.18%	-394.86%	2.08%	-28.57%	-17.08%	2.78%	43.37%	-389.84%	-502.25%	-34.17%	-32.74%
Profit (Net Income) Margin	-111.48%	-395.79%	-2.58%	-38.15%	-26.69%	-14.30%	17.25%	-409.84%	-444.50%	-37.25%	-47.72%
Tax Burden Percent	-846.48%	98.86%	237.67%	116.56%	122.40%	-3,338.73%	40.99%	104.37%	88.05%	100.16%	130.46%
Interest Burden Percent	76.65%	101.39%	-52.30%	114.53%	127.66%	15.40%	96.99%	100.73%	100.51%	108.85%	111.74%
Effective Tax Rate	946.48%	0.00%	0.00%	0.00%	0.00%	3,438.73%	59.01%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-49.68%	-90.82%	-0.51%	-6.18%	-2.69%	-55.59%	6.84%	-127.59%	-214.39%	-14.25%	-9.81%
ROIC Less NNEP Spread (ROIC-NNEP)	-22.12%	-146.77%	-1.07%	-14.53%	-9.74%	23.80%	6.74%	-186.00%	-255.40%	-18.79%	-17.92%
Return on Net Nonoperating Assets (RNNOA)	-2.79%	-20.92%	-0.17%	-2.30%	-1.76%	5.05%	1.49%	-50.45%	-94.61%	-6.89%	-6.45%
Return on Equity (ROE)	-52.48%	-111.74%	-0.68%	-8.47%	-4.45%	-50.54%	8.33%	-178.04%	-309.00%	-21.14%	-16.26%
Cash Return on Invested Capital (CROIC)	-4.14%	15.20%	13.85%	14.84%	3.70%	-1.44%	-6.46%	12.01%	28.64%	26.49%	28.85%
Operating Return on Assets (OROA)	3.85%	-85.62%	0.43%	-5.63%	-3.21%	0.63%	11.59%	-117.02%	-180.79%	-11.33%	-8.49%
Return on Assets (ROA)	-24.96%	-85.82%	-0.54%	-7.51%	-5.02%	-3.22%	4.61%	-123.02%	-160.00%	-12.35%	-12.37%
Return on Common Equity (ROCE)	-52.48%	-111.74%	-0.68%	-8.47%	-4.45%	-50.54%	8.33%	-178.04%	-309.00%	-21.14%	-16.26%
Return on Equity Simple (ROE_SIMPLE)	-7.65%	0.00%	-46.12%	-50.41%	-39.10%	0.00%	-4.14%	-60.88%	-375.63%	0.00%	-527.10%
Net Operating Profit after Tax (NOPAT)	-134	-161	-1.38	-14	-5.95	-130	24	-185	-248	-13	-12
NOPAT Margin	-149.99%	-276.10%	-1.65%	-21.10%	-9.65%	-161.06%	17.36%	-272.86%	-352.19%	-24.56%	-23.29%
Net Nonoperating Expense Percent (NNEP)	-27.56%	55.95%	0.56%	8.35%	7.05%	-79.39%	0.10%	58.41%	41.02%	4.54%	8.11%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	2.38%	-	-	-	-3.15%
Cost of Revenue to Revenue	27.24%	41.94%	31.30%	36.57%	33.96%	28.51%	19.04%	30.79%	28.50%	36.33%	35.02%
SG&A Expenses to Revenue	11.92%	18.42%	17.04%	28.04%	21.11%	14.18%	9.25%	24.56%	13.94%	24.06%	25.06%
R&D to Revenue	29.25%	43.53%	35.26%	41.66%	48.98%	43.51%	24.08%	46.95%	44.21%	46.03%	41.00%
Operating Expenses to Revenue	55.04%	452.49%	71.07%	93.57%	79.83%	66.66%	38.62%	459.01%	574.63%	98.76%	98.25%
Earnings before Interest and Taxes (EBIT)	15	-230	1.74	-20	-11	2.25	60	-264	-354	-19	-17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	-225	6.74	-15	-7.41	5.13	63	-262	-352	-16	-14
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.04	0.87	1.03	1.59	1.68	1.18	1.08	1.42	0.77	0.93	2.79
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.70	1.89	2.33	3.78	4.33	2.79	2.27	1.88	0.33	0.40	1.38
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.04	0.89	1.02	1.49	1.55	1.15	1.07	1.31	0.88	0.97	1.81
Enterprise Value to Revenue (EV/Rev)	3.06	2.33	2.84	4.29	4.94	3.32	2.73	2.35	0.76	0.85	1.97
Enterprise Value to EBITDA (EV/EBITDA)	13.84	0.00	0.00	0.00	0.00	0.00	20.79	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	20.43	0.00	0.00	0.00	0.00	0.00	29.65	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	43.09	0.00	0.00	0.00	0.00	130.24	140.29	635.68	12.19	16.47	16.46
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	5.04	6.35	8.47	37.21	0.00	0.00	9.16	1.62	1.87	2.88
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.38	0.39	0.39	0.40	0.40	0.38	0.60	1.82	2.00	2.12
Long-Term Debt to Equity	0.27	0.36	0.37	0.37	0.36	0.40	0.38	0.60	1.25	1.38	1.63
Financial Leverage	0.13	0.14	0.16	0.16	0.18	0.21	0.22	0.27	0.37	0.37	0.36
Leverage Ratio	1.67	1.73	1.72	1.72	1.75	1.86	1.80	1.98	2.32	2.39	2.21
Compound Leverage Factor	1.28	1.76	-0.90	1.97	2.23	0.29	1.75	1.99	2.33	2.60	2.47
Debt to Total Capital	22.17%	27.50%	27.99%	28.09%	28.45%	28.42%	27.51%	37.57%	64.52%	66.64%	67.97%
Short-Term Debt to Total Capital	0.77%	1.11%	1.25%	1.27%	2.51%	0.00%	0.00%	0.00%	20.01%	20.59%	15.91%
Long-Term Debt to Total Capital	21.40%	26.38%	26.74%	26.83%	25.93%	28.42%	27.51%	37.57%	44.51%	46.05%	52.06%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	77.83%	72.50%	72.01%	71.91%	71.55%	71.58%	72.49%	62.43%	35.48%	33.36%	32.03%
Debt to EBITDA	3.33	-1.67	-1.52	-1.31	-1.17	-27.45	6.05	-1.39	-0.51	-0.50	-0.40
Net Debt to EBITDA	1.65	-0.89	-0.86	-0.73	-0.68	-15.42	3.51	-0.81	-0.28	-0.27	-0.23
Long-Term Debt to EBITDA	3.21	-1.61	-1.45	-1.25	-1.06	-27.45	6.05	-1.39	-0.35	-0.34	-0.30
Debt to NOPAT	-2.77	-2.10	-1.91	-1.68	-1.53	-14.49	-6.25	-1.89	-0.72	-0.69	-0.56
Net Debt to NOPAT	-1.38	-1.11	-1.09	-0.93	-0.90	-8.14	-3.63	-1.11	-0.40	-0.37	-0.32
Long-Term Debt to NOPAT	-2.68	-2.01	-1.83	-1.60	-1.40	-14.49	-6.25	-1.89	-0.50	-0.48	-0.43
Altman Z-Score	1.24	0.06	0.72	1.00	1.04	0.76	1.08	-0.46	-2.84	-1.23	-1.34
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.65	1.55	1.47	1.40	1.30	1.52	1.90	2.18	1.31	1.22	1.32
Quick Ratio	1.23	1.09	1.05	1.02	0.95	1.16	1.39	1.64	1.06	0.88	1.02
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-82	120	287	303	212	-123	11	52	309	544	614
Operating Cash Flow to CapEx	-88.61%	-163.57%	-310.10%	470.23%	-539.28%	737.26%	-302.36%	56.59%	1,660.47%	422.89%	680.44%
Free Cash Flow to Firm to Interest Expense	-21.48	31.64	81.64	75.59	51.55	-39.39	3.46	16.64	99.71	175.32	180.99
Operating Cash Flow to Interest Expense	-1.03	-1.31	-0.60	1.64	-1.99	3.59	-0.87	0.34	4.14	1.97	2.73
Operating Cash Flow Less CapEx to Interest Expense	-2.19	-2.10	-0.80	1.29	-2.36	3.11	-1.16	-0.26	3.89	1.51	2.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.22	0.21	0.20	0.19	0.23	0.27	0.30	0.36	0.33	0.26
Accounts Receivable Turnover	6.35	7.24	6.09	5.47	4.54	5.54	5.58	5.44	5.51	5.35	4.59
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	10.70	9.48	8.89	8.22	7.45	8.21	10.04	10.27	10.89	10.34	7.87
Accounts Payable Turnover	7.30	8.83	7.23	5.37	6.13	6.99	4.98	5.15	6.84	8.37	5.88
Days Sales Outstanding (DSO)	57.48	50.45	59.97	66.77	80.34	65.91	65.41	67.14	66.26	68.28	79.53
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	50.01	41.34	50.49	67.93	59.54	52.25	73.30	70.89	53.37	43.58	62.10
Cash Conversion Cycle (CCC)	7.46	9.11	9.47	-1.16	20.81	13.66	-7.89	-3.76	12.89	24.70	17.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,085	857	879	864	866	850	892	627	308	293	266
Invested Capital Turnover	0.33	0.33	0.31	0.29	0.28	0.35	0.39	0.47	0.61	0.58	0.42
Increase / (Decrease) in Invested Capital	-52	-281	-288	-317	-218	-6.72	13	-237	-558	-557	-626
Enterprise Value (EV)	1,126	764	900	1,284	1,342	977	954	820	272	283	482
Market Capitalization	992	620	740	1,130	1,178	822	793	656	118	132	336
Book Value per Share	$24.17	$18.10	$18.02	$17.64	$17.44	$17.23	$17.75	$11.12	$3.69	$3.38	$2.82
Tangible Book Value per Share	($4.50)	($4.76)	($4.75)	($4.97)	($5.13)	($5.19)	($4.34)	($4.56)	($3.36)	($3.77)	($3.95)
Total Capital	1,221	983	1,000	987	982	971	1,009	742	435	423	377
Total Debt	271	270	280	277	279	276	277	279	280	282	256
Total Long-Term Debt	261	259	267	265	255	276	277	279	193	195	196
Net Debt	134	144	160	154	163	155	161	164	154	151	146
Capital Expenditures (CapEx)	4.43	3.03	0.68	1.39	1.52	1.53	0.93	1.85	0.77	1.45	1.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-24	-18	-29	-27	-33	-0.14	18	22	8.81	0.05
Debt-free Net Working Capital (DFNWC)	110	91	89	78	75	78	108	126	143	136	108
Net Working Capital (NWC)	101	80	77	66	51	78	108	126	56	49	48
Net Nonoperating Expense (NNE)	-34	70	0.77	12	11	-119	0.16	93	65	6.96	12
Net Nonoperating Obligations (NNO)	134	144	160	154	163	155	161	164	154	151	146
Total Depreciation and Amortization (D&A)	5.28	5.09	5.01	5.03	3.12	2.89	2.69	2.70	2.67	2.58	2.45
Debt-free, Cash-free Net Working Capital to Revenue	-4.68%	-7.24%	-5.59%	-9.57%	-10.08%	-11.12%	-0.04%	5.04%	6.24%	2.66%	0.02%
Debt-free Net Working Capital to Revenue	29.94%	27.88%	28.20%	26.20%	27.74%	26.36%	31.04%	36.17%	40.08%	40.96%	44.27%
Net Working Capital to Revenue	27.40%	24.55%	24.26%	22.02%	18.65%	26.36%	31.04%	36.17%	15.75%	14.69%	19.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.53)	($5.88)	($0.05)	($0.65)	($0.41)	($0.29)	$0.58	($6.66)	($7.50)	($0.54)	($0.57)
Adjusted Weighted Average Basic Shares Outstanding	39.31M	39.19M	39.96M	40.22M	40.32M	40.22M	41.19M	41.72M	41.80M	41.64M	42.90M
Adjusted Diluted Earnings per Share	($2.53)	($5.86)	($0.05)	($0.65)	($0.41)	($0.29)	$0.53	($6.66)	($7.50)	($0.49)	($0.57)
Adjusted Weighted Average Diluted Shares Outstanding	39.31M	39.19M	39.96M	40.22M	40.32M	40.22M	49.26M	41.72M	41.80M	41.64M	42.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($0.05)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.38M	39.94M	40.23M	40.31M	40.33M	41.14M	41.67M	41.78M	41.80M	42.83M	43.20M
Normalized Net Operating Profit after Tax (NOPAT)	12	-159	1.55	-10	-5.13	3.32	41	-5.42	2.56	-6.23	-4.11
Normalized NOPAT Margin	13.34%	-273.23%	1.85%	-15.25%	-8.32%	4.11%	30.00%	-7.98%	3.63%	-11.36%	-8.07%
Pre Tax Income Margin	13.17%	-400.37%	-1.09%	-32.73%	-21.80%	0.43%	42.07%	-392.67%	-504.82%	-37.19%	-36.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.01	-60.55	0.49	-4.88	-2.56	0.72	18.54	-84.99	-114.14	-6.04	-4.91
NOPAT to Interest Expense	-35.01	-42.33	-0.39	-3.61	-1.44	-41.53	7.42	-59.49	-80.04	-4.34	-3.49
EBIT Less CapEx to Interest Expense	2.85	-61.34	0.30	-5.23	-2.93	0.23	18.25	-85.58	-114.39	-6.50	-5.31
NOPAT Less CapEx to Interest Expense	-36.17	-43.13	-0.59	-3.95	-1.81	-42.02	7.13	-60.08	-80.29	-4.81	-3.89
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-82.03%	-15.77%	-2.13%	-1.96%	-2.14%	-8.70%	-27.98%	-3.62%	-1.71%	-1.68%	-0.79%

Frequently Asked Questions About Cerence's Financials

When does Cerence's financial year end?

According to the most recent income statement we have on file, Cerence's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Cerence's net income changed over the last 2 years?

Cerence's net income appears to be on an upward trend, with a most recent value of -$588.08 million in 2024, rising from -$310.83 million in 2022. The previous period was -$56.25 million in 2023.

What is Cerence's operating income?

Cerence's total operating income in 2024 was -$579.94 million, based on the following breakdown:

Total Gross Profit: $244.27 million
Total Operating Expenses: $824.21 million

How has Cerence revenue changed over the last 2 years?

Over the last 2 years, Cerence's total revenue changed from $327.89 million in 2022 to $331.50 million in 2024, a change of 1.1%.

How much debt does Cerence have?

Cerence's total liabilities were at $561.26 million at the end of 2024, a 6.9% decrease from 2023, and a 7.3% decrease since 2022.

How much cash does Cerence have?

In the past 2 years, Cerence's cash and equivalents has ranged from $94.85 million in 2022 to $121.49 million in 2024, and is currently $121.49 million as of their latest financial filing in 2024.

How has Cerence's book value per share changed over the last 2 years?

Over the last 2 years, Cerence's book value per share changed from 18.10 in 2022 to 3.38 in 2024, a change of -81.4%.

Related Companies

This page (NASDAQ:CRNC) was last updated on 4/18/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cerence (CRNC) Financials

Frequently Asked Questions About Cerence's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cerence (CRNC) Financials

Annual Income Statements for Cerence

Quarterly Income Statements for Cerence

Annual Cash Flow Statements for Cerence

Quarterly Cash Flow Statements for Cerence

Annual Balance Sheets for Cerence

Quarterly Balance Sheets for Cerence

Annual Metrics and Ratios for Cerence

Quarterly Metrics and Ratios for Cerence

Frequently Asked Questions About Cerence's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools